Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
It may not always be necessary to subject heart transplant patients to one biopsy after another.
Radiation in the cath lab: Tracking state-level regulations for cardiologists
Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.
Wrongful death lawsuit filed after restrained hospital patient dies of cardiac arrest
The family of Gay Sherman Weintz, 55, said she died as a result of 24-hour physical restraint, combined with staff at Middlesex Hospital ignoring signs of a medical crisis. Her son, Chauncey Smith, has filed a wrongful death lawsuit.
Lab owner indicted in $290M COVID fraud scheme pleads not guilty
Mahmood Sami Khan, 36, has been charged on five counts of wire fraud and money laundering in connection with the conspiracy. If convicted, he could spend the rest of his life behind bars.
PFA market heats up as medtech companies announce new investments
While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias.

Treating type 2 diabetes with ertugliflozin does not increase risk of major cardiovascular events

The VERTIS CV Study tracked the performance of ertugliflozin and a placebo in more than 8,000 adult T2D patients.

Azithromycin associated with greater risk of cardiovascular death, but not sudden cardiac death

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.

Dexamethasone improves outcomes for critically ill COVID-19 patients

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Cleveland Clinic develops first risk prediction model for COVID-19 patients

Researchers at Cleveland Clinic have created the first risk prediction model that allows healthcare providers to find the likelihood of an individual patient testing positive for COVID—19, as well as possible outcomes from the virus.

Even mild myocardial injuries are a bad sign for COVID-19 patients

Researchers have found a link between myocardial injury and a higher risk of death among patients hospitalized in the United States for COVID-19.

First drug found to improve COVID-19 survival

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

FDA says hydroxychloroquine unlikely to be effective in treating COVID-19

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

Update: FDA names 5 companies recalling extended-release metformin

The FDA has provided new information about the metformin recall first announced in May.

Clinical

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients

Radiation in the cath lab: Tracking state-level regulations for cardiologists

Wrongful death lawsuit filed after restrained hospital patient dies of cardiac arrest

Lab owner indicted in $290M COVID fraud scheme pleads not guilty

PFA market heats up as medtech companies announce new investments